Biologist Larry Gold has taught and worked at CU Boulder since 1970. He鈥檚 regarded internationally for his DNA and RNA research, which has spawned numerous discoveries and commercially successful biotechnology patents; and CU honored his work by naming the Gold Bioscience Building after him. But Gold鈥檚 research extends well beyond campus. He co-founded the biotech company Synergen in 1981, when biotechnology was still an emerging field. In 1992, he founded NeXagen, now part of Gilead Sciences, which develops products for infectious disease treatments. And in 2000, he founded yet another biotech company, SomaLogic, whose goal is to transform how diseases are detected and diagnosed. 鈥淭he environment for world-class science at CU is great,鈥� says Gold. 鈥淎nd it鈥檚 a place where you can work as hard as you want and start companies鈥擨鈥檝e started three. I consider myself lucky to have been here.鈥�
听
听
